We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.02B
AUM Growth
+$50.3M
Cap. Flow
-$29M
Cap. Flow %
-2.85%
Top 10 Hldgs %
43.62%
Holding
67
New
3
Increased
32
Reduced
17
Closed
11

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$28.1M
2
PFE icon
Pfizer
PFE
+$17.7M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$13.7M
4
NVO
Novo Nordisk
NVO
+$11.4M
5
MRK icon
Merck
MRK
+$11.2M

Top Sells

Rank Stock Value
1
ADPT
Adeptus Health Inc
ADPT
+$32M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$29.3M
3
UNH icon
UnitedHealth
UNH
+$20.5M
4
VTRS icon
Viatris
VTRS
+$17.6M
5
SGNT
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 94.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$315B
$57.7M 5.67%
969,578
+190,956
+25% +$11.2M
PFE icon
2
Pfizer
PFE
$143B
$57.4M 5.63%
1,785,167
+528,451
+42% +$17.7M
CELG
3
DELISTED
Celgene Corp
CELG
$50.4M 4.95%
482,118
+65,414
+16% +$7.08M
LLY icon
4
Eli Lilly
LLY
$1.05T
$48.8M 4.79%
607,427
+77,519
+15% +$6.2M
MDT icon
5
Medtronic
MDT
$106B
$45M 4.42%
521,241
+95,908
+23% +$8.36M
GILD icon
6
Gilead Sciences
GILD
$167B
$41.5M 4.07%
524,165
+48,063
+10% +$3.9M
NBIX icon
7
Neurocrine Biosciences
NBIX
$17.2B
$40.7M 3.99%
802,979
-209,227
-21% -$10.4M
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$11.5B
$38.1M 3.74%
411,317
-83,519
-17% -$7.86M
ABMD
9
DELISTED
Abiomed Inc
ABMD
$32.6M 3.2%
253,745
-44,593
-15% -$5.34M
PTLA
10
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$32.2M 3.16%
1,419,208
+189,826
+15% +$4.46M
SHPG
11
DELISTED
Shire pic
SHPG
$32.2M 3.16%
166,093
+17,669
+12% +$3.45M
FOLD
12
DELISTED
Amicus Therapeutics
FOLD
$31M 3.05%
4,194,452
-594,286
-12% -$4.01M
NXTM
13
DELISTED
NxStage Medical Inc.
NXTM
$30M 2.94%
1,199,869
-628,713
-34% -$14.7M
ACHC icon
14
Acadia Healthcare
ACHC
$3.17B
$28.6M 2.81%
576,769
+96,164
+20% +$5.01M
TDOC icon
15
Teladoc Health
TDOC
$1.7B
$28.2M 2.77%
1,539,618
+75,397
+5% +$1.32M
DXCM icon
16
DexCom
DXCM
$29.6B
$28.2M 2.77%
1,286,008
-291,856
-18% -$6.5M
CI icon
17
Cigna
CI
$74.5B
$28M 2.75%
+215,080
New +$28.1M
GBT
18
DELISTED
Global Blood Therapeutics, Inc.
GBT
$23.8M 2.33%
1,031,449
+44,225
+4% +$843K
ALGN icon
19
Align Technology
ALGN
$12.7B
$22.7M 2.23%
242,641
-3,486
-1% -$315K
INCY icon
20
Incyte
INCY
$23.4B
$21.1M 2.07%
223,663
-24,796
-10% -$2.09M
TEVA icon
21
Teva Pharmaceuticals
TEVA
$37.3B
$20.9M 2.05%
454,172
-161,763
-26% -$8.44M
ISRG icon
22
Intuitive Surgical
ISRG
$122B
$20.5M 2.01%
254,826
+81,360
+47% +$6.23M
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$123B
$19M 1.87%
217,874
-13,701
-6% -$1.29M
NVO
24
Novo Nordisk
NVO
$223B
$18.5M 1.82%
890,750
+458,400
+106% +$11.4M
ISEE
25
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$18M 1.76%
389,363
+242,563
+165% +$13.7M
1
2 3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
FWA
Fulcrum Wealth Advisors Bellevue, Washington $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM

Sectoral Asset Management's Q3 2016 Portfolio in Review

As of Q3 2016, Sectoral Asset Management held 67 positions worth $1.02B, up 5.2% from $968M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sectoral Asset Management's Q3 2016 filing shows 3 new, 32 increased, 17 reduced and 11 closed positions. Its largest new stake was Cigna: 215,080 shares worth $28M. The largest sale was Adeptus Health Inc, an estimated $32M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 94% a quarter earlier.

  • Sectoral Asset Management's largest Q3 2016 buy was Cigna: 215,080 shares worth $28M.
  • Sectoral Asset Management added most to Pfizer in Q3 2016, an estimated $17.7M increase.
  • Sectoral Asset Management's biggest Q3 2016 reduction was NxStage Medical Inc., cutting an estimated $14.7M.
  • Sectoral Asset Management fully exited Adeptus Health Inc in Q3 2016, selling an estimated $32M.
  • Sectoral Asset Management's ten largest holdings make up 44% of its $1.02B portfolio in Q3 2016.
  • Sectoral Asset Management opened 3 new positions and closed 11 in Q3 2016.
  • Sectoral Asset Management's portfolio value rose 5.2% quarter-over-quarter to $1.02B.

Based on Sectoral Asset Management's 13F filing for Q3 2016, filed 10 Nov 2016.